Nucleic acid detection tests for MRSA and VRE rapid diagnostics for HUS and ISLAB Text automatically translated in your browsing language Automatically translated

The HUS Group invites tenders for nucleic acid detection tests for MRSA and VRE rapid diagnostics to be used by the HUS Diagnostic Centre (hereinafter also referred to as HUS) and the ISLAB Welfare Group (hereinafter referred to as ISLAB). The tests must be CE IVD marked and suitable for use in laboratories with existing GeneXpert (Cepheid) equipment. Diagnostics are performed at the following HUS and ISLAB units: HUS Unit of Bacteriology, Helsinki HUS Clinical Microbiology of Kymenlaakso Central Hospital, Kotka HUS Clinical Microbiology of South Karelia Central Hospital, Lappeenranta ISLAB Clinical Microbiology Kuopio ISLAB Clinical Microbiology Joensuu ISLAB Clinical Microbiology Mikkeli Consumption estimates: HUS approximately 90 VRE tests per year and approximately 1300 MRSA tests per year (consumption in 2022-2024) ISLAB approximately 120 VRE tests per year and approximately 300 MRSA tests per year (consumption in 2022-2024) Analytics are performed daily, mainly during daytime. In the units of Helsinki and ISLAB also possibly during on-call time. The consumption of tests varies from year to year depending on the epidemic situation. The above estimates are based on the actual figures for the previous years 2022-2024. Contracting entities shall not commit themselves to the actual quantities of consumption indicated in the invitation to tender. Final order quantities may be higher or lower than indicated. The subject-matter and requirements of the contract are described in detail in the invitation to tender and its annexes. The contract period for the tests is two (2) years. The contract will continue for an indefinite period after the fixed term. One (1) Supplier will be selected as the Contractor. HUS and ISLAB sign their own agreements. The aim is to use competitive tendering to obtain a reliable test method suitable for rapid diagnostics from MRSA and VRE. In addition, the aim is to ensure the security of supply of products. The subject matter of the purchase also includes additional products related to the offered products, such as additional sizes and accessories, which are indicated in the Product and Price Annex. In addition, products belonging to the product groups covered by the contract that are not specified in the product annex (see draft contract) may be procured during the contract period according to the estimated value of the procurement. Products belonging to product groups refer, for example, to alternative packaging sizes or, as test technology evolves, to new test versions for the same use on the market and sold at the same offer price. Text automatically translated in your browsing language Automatically translated

33000000 - Medical equipments, pharmaceuticals and personal care products

33600000 - Pharmaceutical products CVP code deduced from the text of the procedure AI-generated